Alloplex Biotherapeutics Funding & Investors
Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor types and is particularly suited to combinations with checkpoint inhibitors. Alloplex is a private company and currently supported by angel investment
alloplexbio.comTotal Amount Raised: $21,200,000
Alloplex Biotherapeutics Funding Rounds
Series A
$20,000,000
Corporate Round
$1,000,000
Corporate Round Investors
Daewoong Pharmaceutical Co.HanAll BiopharmaSeed
$200,000
Funding info provided by Diffbot.